Product Information
AZITHROMYCIN 250 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2656 per EA under NDC 68180086106. Its NADAC has been published 174 times since Jun 7, 2023.
FDA first approved this application on May 15, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180086106
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA065398FDA Approved
5/15/2015
TE Code
AB
On Market Since
11/17/2022
Pharmacological Classes
Price Statistics
The NADAC for AZITHROMYCIN 250 MG TABLET has been published 174 times since Jun 7, 2023, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2656 per EA |
|---|---|
| All-time high | $0.3985 (Aug 14, 2024) |
| All-time low | $0.2563 (Nov 20, 2024) |
| 52-week high | $0.3575 |
| 52-week low | $0.2656 |
| Median price | $0.3535 |
| Average price | $0.3408 |
| Largest weekly change | -35.6% (Nov 20, 2024) |
| Weeks tracked | 174 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
azithromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZITHROMYCIN 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZITHROMYCIN 250 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.2656 per EA (NDC 68180086106), effective Sep 30, 2026.
How has the price of AZITHROMYCIN 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZITHROMYCIN 250 MG TABLET has declined 21.4%. It has been tracked across 174 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for AZITHROMYCIN 250 MG TABLET?
Since Jun 7, 2023, the NADAC for AZITHROMYCIN 250 MG TABLET has ranged from a low of $0.2563 (Nov 20, 2024) to a high of $0.3985 (Aug 14, 2024), with a median of $0.3535 per EA.
Are there cheaper alternatives to AZITHROMYCIN 250 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AZITHROMYCIN 250 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures AZITHROMYCIN 250 MG TABLET?
AZITHROMYCIN 250 MG TABLET (NDC 68180086106) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.